Related Experiment Video
Updated: Sep 7, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae
D E Briles1, S K Hollingshead, G S Nabors
1Department of Microbiology, University of Alabama at Birmingham (UAB), Birmingham, AL 35294-2170, USA. dbriles@uab.edu
Abstract:
Potential vaccine strategies against otitis media are to prevent (1) symptomatic infections in the middle ear and/or (2) carriage of pneumococci and thereby subsequent middle ear infections. The possibility of using immunity to virulence proteins of pneumococci to elicit immunity against pneumococci has been examined. PspA has been found to have efficacy against otitis media in animals. Vaccination with a mixture of PsaA and PspA has been observed to offer better protection against nasal carriage in mice, than vaccination with either protein alone. PspA and pneumolysin have been shown to elicit protection against invasive infections. The inclusion of a few of these proteins into the polysaccharide-protein conjugate vaccines may be able to enhance their efficacy against otitis media and might be able to constitute a successful all-protein pneumococcal vaccine.
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Streptococcal Pharyngitis
Mechanism of Antibiotic Resistance in MRSA
Respiratory Syncytial Virus Disease
Bacterial Meningitis II: Pathophysiology

